You have 9 free searches left this month | for more free features.

Condition

Charcot-Marie-Tooth Disease (2)

Facioscapulohumeral Muscular Dystrophy (1)

Musculoskeletal Diseases (1)

Overall Status

Terminated (2)

Completed (1)

Sign in for free

Phase

phase 2 (2)

phase 1 (1)

Sponsor

Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.) (3)

Collaborator

Intervention

ace-083 (3)

placebo (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

ace-083

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Musculoskeletal Diseases Trial in Lincoln (ACE-083)

Completed

Has Results

Musculoskeletal Diseases

ACE-083

Lincoln, Nebraska

Acceleron Investigative Site

Sep 12, 2022

Charcot-Marie-Tooth Disease Trial in United States (ACE-083, Placebo)

Terminated

Has Results

Charcot-Marie-Tooth Disease

ACE-083
Placebo

Orange, California
+15 more

Sep 13, 2022

Facioscapulohumeral Muscular Dystrophy, Charcot-Marie-Tooth Disease Trial in Canada, Spain, United States (ACE-083)

Terminated

Has Results

Facioscapulohumeral Muscular Dystrophy
Charcot-Marie-Tooth Disease

ACE-083

Orange, California
+23 more

Sep 13, 2022